- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Appoints VP of Business Development and Director of Business Development
Applied Nanotech Holdings, Inc. /quotes/comstock/11k!apnt (APNT 0.28, -0.01, -3.45%) is pleased to announce that as part of its near and long-term commercialization strategy, it has named Dr. Samuel Kim as Vice-President of Business Development and hired Shahar Bar-Cohav as Director of Business Development.
Dr. Kim, who has been with APNT since February 2009, has both Bachelor of Science and Master of Science degrees in mechanical engineering from Stanford University and a Dual PhD in Electrical Engineering and Nanotechnology from the University of Washington. Dr. Kim has over 9 years of experience in high technology venture formation with several startups in the biotechnology, medical devices, semiconductors, and automotive industries. The depth of his technical expertise coupled with his business background is very instrumental to shape the future direction of Applied Nanotech toward technology commercialization.
Shahar Bar-Cohav has a Master of Business Administration degree from the Stephen M. Ross School of Business at the University of Michigan-Ann Arbor, with emphases in marketing and corporate strategy, and a law degree (magna cum laude) from Tel Aviv University. Prior to joining APNT, Mr. Bar-Cohav practiced law for four years as a commercial attorney, specializing in licensing, joint-venture, investment transactions, and due diligence investigations. In addition, Mr. Bar-Cohav completed marketing and business development consulting projects for Baxter Healthcare Corporation, and Bristol-Myers Squibb, relating to the launch of new products, and identification of new markets and commercial collaboration opportunities,
"Our unique approach to nanotechnology and the excellent R&D results that we have achieved thus far have brought us to the point of needing focused commercialization efforts for our technologies. Enhancing our team with Sam and Shahar underlines our continued growth and steadfast performance in driving commercialization of our technologies, " said Dr. Zvi Yaniv, president/CEO of ANI.
"We are thrilled to have two such highly qualified professionals leading our business development effort," said Doug Baker, CEO of APNT. "We are increasing our focus on business development and commercializing our technologies. Sam and Shahar's skills and experience will be very valuable to us in this effort."
APNT has also posted a brief shareholder letter primarily related to the upcoming shareholders meeting on its website at www.appliednanotech.net.
Safe Harbor Statement
This release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report on Form 10-K for the fiscal year ended December 31, 2009, and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at www.sec.gov or from our website listed above. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.
About Applied Nanotech
APNT is a premier research and commercialization organization focused on solving problems at the molecular level. Its team of PhD level scientists and engineers work with companies and other organizations to solve technical impasses and create innovations that will create a competitive advantage. The business model is to license patents and technology to partners that will manufacture and distribute products using the technology. Applied Nanotech has over 250 patents or patents pending.
For more information, please click here
Applied Nanotech Holdings, Inc.
Copyright © Applied NanotechIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Graphenea celebrates fifth anniversary April 27th, 2015
Dais Analytic Corporation Appoints Eliza Wang to Board of Directors: Company's Newest Director Brings Expertise in Commercial and Legal Matters Both in the United States and China; Joins on the Heels of Successful Business Development Trade Mission to China April 18th, 2015
Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015